Pathstone Family Office, LLC Teva Pharmaceutical Industries LTD Transaction History

Pathstone Family Office, LLC

  • $15.6 Billion
  • Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Pathstone Family Office, LLC holds 62,564 shares of TEVA stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,564
Holding current value
$1.05 Million
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$7.48 - $10.7 $467,978 - $669,434
62,564 New
62,564 $638,000
Q4 2022

Oct 23, 2023
SELL
$7.95 - $9.48 $33,684 - $40,166
-4,237 Reduced 41.84%
5,890 $53,000
Q4 2022

Feb 13, 2023
SELL
$7.95 - $9.48 $33,684 - $40,166
-4,237 Reduced 41.84%
5,890 $53,000
Q3 2022

Oct 23, 2023
BUY
$6.86 - $11.95 $69,471 - $121,017
10,127 New
10,127 $81,000
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $69,471 - $121,017
10,127 New
10,127 $82,000
Q1 2021

May 14, 2021
SELL
$10.34 - $12.81 $5,366 - $6,648
-519 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$8.61 - $11.04 $25,830 - $33,120
-3,000 Reduced 85.25%
519 $5,000
Q3 2020

Nov 12, 2020
BUY
$8.57 - $12.69 $25,710 - $38,070
3,000 Added 578.03%
3,519 $32,000
Q1 2020

Jun 11, 2020
BUY
$6.69 - $13.45 $3,472 - $6,980
519 New
519 $5,000
Q4 2019

Feb 14, 2020
SELL
$6.53 - $10.72 $3,389 - $5,563
-519 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$14.59 - $23.84 $4,508 - $7,366
309 Added 147.14%
519 $8,000
Q3 2018

Nov 09, 2018
BUY
$21.06 - $25.65 $4,422 - $5,386
210 New
210 $5,000

Others Institutions Holding TEVA

# of Institutions
541
Shares Held
548M
Call Options Held
19.8M
Put Options Held
14M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.7B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email